Dr. Wagner is a clinical nephrologist. He is the Director of the Kidney Institute of New Mexico as well as being the acting Associate Chief of Research and Renal Section Chief for the VA in Albuquerque.
In this episode we discuss recent evidence urging caution over the use of gadolinium based contrast agents.
To fund Dr. Wagner’s work you can donate to the Kidney Institute of New Mexico at
https://www.unmfund.org/fund/unm-kidn...
Links:
Reveal Pharmaceuticals, Gadolinium-free MRI contrast agents products.
http://www.revealpharma.com
Peter Caravan PhD. Director, Institute for Innovation in Imaging Massachusetts and Associate Professor of Radiology at Harvard Medical School.
Twitter- @PeterCaravan
The FDA adverse event reporting system
https://open.fda.gov/data/faers/
Gadolinium-based contrast agents: why nephrologists need to be concerned
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416778/